Skip to main content

Novel fatty acid conjugated tetrapeptide as a new biological active molecule for wound treatment

Healthcare and Medical Devices las la-heartbeat green
Potential Commercialised fa-solid fa-cart-arrow-down violet
Reg. ID : 16196
Comments

Description

The present invention relates to a potential wound healing agent that composed of a new palmitic acid conjugated tetrapeptide (Glycine - Aspartic acid - Proline - Histidine) known as Palmitoyl-GDPH. From the in-vitro wound scratch assay, it revealed the benefits in providing a favourable environment for cell growth. Besides, the 4 cm2 full thickness wound treated with this therapeutic peptide demonstrated 100 % healing within 18 days, increased re-epithelization, enhanced collagen deposition and diminished scar formation compared to the control group. Moreover, from hematological and biochemical study, topical application of Palmitoyl-GDPH resulted in no significant toxicity and no systemic side effect in the liver, kidney and pancreas of the experimental animals.

Contact Person/Inventor

Name Email Contact Phone
Haslina Binti Ahmad haslina_ahmad@upm.edu.my 03-97697486

Intellectual Property

Type of IP Registration ID
1 Patent Filed PI 2018702490

Award

Loading, please wait
Award Title
Award Achievement
Award Year Received
000

Comment

LOG IN or REGISTER to post comments.

Star Rating

Star Rating
No votes yet

Contact Form